Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Dynamics and Amersham Sign Dupont As Microarray Partner

Premium

SUNNYVALE, Calif.--Molecular Dynamics here, in partnership with Amersham International, has entered an agreement with Dupont Agricultural Products to continue development of microarray technologies that speed genetic research. Under terms of the deal, Dupont will provide funding and share its expertise, in exchange for early access to the technologies, which Dupont will use to study gene expression levels in agricultural seed and plant species and to develop products that improve the health and disease-resistance of agricultural plants.

While Molecular Dynamics and Amersham have six other collaborators involved with their microarray technology, Dupont is the first in the agricultural area, they noted.

In other news, Molecular Dynamics has released third quarter results that show gains in revenues, net income, and net per share for both the three- and nine-month periods ended September 30, compared to the same periods in 1996.

For the quarter, the company posted revenues of $14.37 million, net income of $1.38 million, and earning of 12 cents per share. Year-ago figures were $12.91 million, $1.07 million, and 10 cents a share.

During the past nine months, Molecular Dynamics had revenues of $41.25 million, net income of $3.97 million, and earnings of 35 cents per share. Comparable 1996 results were $35.95 million, $1.99 million, and 19 cents a share. Molecular Dynamics makes systems for genetic research. The company recently announced a new high-throughput DNA sequencing and mapping device that will become commercially available in 1998.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.